BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26237885)

  • 1. [Diagnosis and treatment of actinic keratosis].
    Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
    Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinic keratoses: past, present and future.
    Fenske NA; Spencer J; Adam F
    J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical and light-based treatments for actinic keratoses.
    Silapunt S; Goldberg LH; Alam M
    Semin Cutan Med Surg; 2003 Sep; 22(3):162-70. PubMed ID: 14649583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for actinic keratoses.
    McIntyre WJ; Downs MR; Bedwell SA
    Am Fam Physician; 2007 Sep; 76(5):667-71. PubMed ID: 17894135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
    Samrao A; Cockerell CJ
    Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis.
    Hansen JB; Larsson T; Dunkelly-Allen N; Veverka KA; Feldman SR
    J Drugs Dermatol; 2020 Aug; 19(8):756-762. PubMed ID: 32804451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
    McGillis ST; Fein H
    Semin Cutan Med Surg; 2004 Sep; 23(3):174-83. PubMed ID: 15584683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in the treatment of actinic keratoses?
    Frankel A; Goldenberg G
    Cutis; 2011 Feb; 87(2):62-4. PubMed ID: 21416769
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
    Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
    Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
    Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
    Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment of actinic keratoses.
    Uhlenhake EE
    Clin Interv Aging; 2013; 8():29-35. PubMed ID: 23345970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic keratosis - review for clinical practice.
    de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
    Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
    Werner RN; Jacobs A; Rosumeck S; Erdmann R; Sporbeck B; Nast A
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):e1-66. PubMed ID: 26350885
    [No Abstract]   [Full Text] [Related]  

  • 17. Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Heron CE; Feldman SR
    J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actinic keratosis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Jun; 148(24):38-9, 41. PubMed ID: 16850807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.